| Wissenschaftl. Titel | Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B) |
| Erkrankung |
Haema:
NHL: Mantel-Zell-Lymphom:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
erstellt 25.04.2024 Data entry III CCP
geändert 01.07.2024 Data entry IX CCP